Results 151 to 160 of about 1,676,067 (279)

Assessment of Clinical Drug-Drug Interactions of Elagolix, a Gonadotropin-Releasing Hormone Receptor Antagonist. [PDF]

open access: yesJ Clin Pharmacol, 2020
Polepally AR   +8 more
europepmc   +1 more source

Intramuscular pathways of maladaptation in overtraining syndrome

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend The transition from adaptive overreaching to maladaptive overtraining and mechanisms through which excessive training load can lead to performance decline. Four interconnected pathophysiological domains are highlighted: neural fatigue, involving both central and peripheral components such as altered sensory feedback and reflex ...
Emily Shorter   +4 more
wiley   +1 more source

Human placental exposure to pollutant nanoparticles: uptake, translocation and functional impact

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Prenatal exposure to pollutant nanoparticles has been increasingly investigated due to concerns about their potential effects on placental function and pregnancy outcomes. Maternal inhalation of pollutant nanoparticles can result in a pro‐inflammatory response; particles can also translocate across the alveolus epithelial barrier
Katherine L. Bethell   +3 more
wiley   +1 more source

Comparative Performance of Kenyan and Imported Artemia in Early Larval Rearing of Clarias gariepinus

open access: yesAquaculture, Fish and Fisheries, Volume 6, Issue 5, October 2026.
ABSTRACT Successful larval rearing of fish depends largely on live feed availability, during the critical first‐feeding stage. In Kenya, hatcheries commonly use phytoplankton or imported Artemia cysts as starter feeds, although locally produced Artemia is available. Hatchery operators' reports on low larval survival when using imported Artemia prompted
Morine M. Ngarari   +9 more
wiley   +1 more source

Rescue of mutant gonadotropin-releasing hormone receptor function independent of cognate receptor activity. [PDF]

open access: yesSci Rep, 2020
Smith E   +6 more
europepmc   +1 more source

Preclinical and Toxicology Studies of LPM7100328, a Novel Oral GnRH Antagonist

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 5, October 2026.
ABSTRACT LPM7100328 is a novel oral GnRH antagonist being developed for the prevention of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian stimulation. The studies presented herein reported assessment of safety in favor of human clinical trials.
Yao Wang   +9 more
wiley   +1 more source

Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis. [PDF]

open access: yesClin Pharmacokinet, 2020
Shebley M   +8 more
europepmc   +1 more source

Fertility‐Sparing Treatment of Endometrial Cancer: Survey of Australian Practice

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 5, October 2026.
ABSTRACT Background Endometrial cancer is the most common gynaecological malignancy in Australia. Patients diagnosed in their reproductive window may desire a fertility‐sparing approach, opposed to standard surgical care. International guidelines on fertility‐sparing management exist; however, these highlight the lack of high‐level evidence to support ...
Harrison Odgers, Rhonda Farrell
wiley   +1 more source

Home - About - Disclaimer - Privacy